NEWS | BEAM Alliance


4th Bacteriophage Therapy Summit

The Bacteriophage Therapy Summit is the definitive gathering for global phage experts. Focusing on human health and disease, the 4th Bacteriophage Therapy Summit is returning to help you advance your phage-based therapies through clinical development and commercialization beyond compassionate use.

Date: February 14-16, 2022
Time: 9.00 – 5.00 EST | 6.00 – 2.00 PST
Virtual Summit

2022 Agenda at a Glance:
-Navigate clinical trial rationale, distribution effects of formulation on reaching infection sites, lessons learned from compassionate use trials, and the regulatory pathway for commercial development with the hottest insights from our 35+ expert speaker faculty
-Hear from international organizations including the FDA, BiomX, Locus Bioscience, Felix Bioscience, Phagomed, PhagePro, Cytophage, Sciphage and unite with the phage community prioritizing human health and disease
-Discuss strategies to weaponize phage therapies including lysins, genetic engineered and combination approaches to create new pathways for the treatment of infectious diseases, across 3 days of unparalleled, industry-centered content
-Keep your company’s interest in bacteriophage therapies up-to-date and aligned with the new breakthroughs beyond basic science and establish your pathway to commercialization in 2022 and beyond

See the full speaker faculty, all agenda topics and the attending audience in the event brochure.

Please contact us to benefit from a VIP code to retrieve 10% off registration fee for BEAM Members only!